Literature DB >> 22173435

Neurodegenerative disease: Novel ALS therapy shows promise in Phase II.

Sarah Crunkhorn.   

Abstract

Entities:  

Year:  2011        PMID: 22173435     DOI: 10.1038/nrd3634

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN: 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  1 in total

1.  The effects of dexpramipexole (KNS-760704) in individuals with amyotrophic lateral sclerosis.

Authors:  Merit Cudkowicz; Michael E Bozik; Evan W Ingersoll; Robert Miller; Hiroshi Mitsumoto; Jeremy Shefner; Dan H Moore; David Schoenfeld; James L Mather; Donald Archibald; Mary Sullivan; Craig Amburgey; Juliet Moritz; Valentin K Gribkoff
Journal:  Nat Med       Date:  2011-11-20       Impact factor: 53.440

  1 in total
  1 in total

1.  Insights into the evolutionary features of human neurodegenerative diseases.

Authors:  Arup Panda; Tina Begum; Tapash Chandra Ghosh
Journal:  PLoS One       Date:  2012-10-30       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.